Skip to main content
. 2021 Jun 16;12:650791. doi: 10.3389/fendo.2021.650791

Figure 1.

Figure 1

Targeted drugs to Cushing’s disease and their mechanistic scheme. TMZ, temozolomide; RTK, receptor of tyrosine kinase.